201 related articles for article (PubMed ID: 17786350)
1. Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats.
Ando N; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Tanaka T; Moriwaki H
Oncol Rep; 2007 Oct; 18(4):879-84. PubMed ID: 17786350
[TBL] [Abstract][Full Text] [Related]
2. The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway.
Sakai H; Yamada Y; Kubota M; Imai K; Shirakami Y; Tomita H; Hara A; Shimizu M
Carcinogenesis; 2022 Apr; 43(3):254-263. PubMed ID: 34668523
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
4. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].
Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007
[TBL] [Abstract][Full Text] [Related]
5. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated retinoid X receptor alpha loses its heterodimeric activity with retinoic acid receptor beta.
Yoshimura K; Muto Y; Shimizu M; Matsushima-Nishiwaki R; Okuno M; Takano Y; Tsurumi H; Kojima S; Okano Y; Moriwaki H
Cancer Sci; 2007 Dec; 98(12):1868-74. PubMed ID: 17900311
[TBL] [Abstract][Full Text] [Related]
7. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
Shimizu M; Takai K; Moriwaki H
Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
[TBL] [Abstract][Full Text] [Related]
8. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes.
Wang AG; Song YN; Chen J; Li HL; Dong JY; Cui HP; Yao L; Li XF; Gao WT; Qiu ZW; Wang FJ; Wang JY
Biochem Biophys Res Commun; 2014 Sep; 452(3):801-7. PubMed ID: 25218146
[TBL] [Abstract][Full Text] [Related]
9. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
12. The Roles of GSK-3β in Regulation of Retinoid Signaling and Sorafenib Treatment Response in Hepatocellular Carcinoma.
Zhang S; Gao W; Tang J; Zhang H; Zhou Y; Liu J; Chen K; Liu F; Li W; To SKY; Wong AST; Zhang XK; Zhou H; Zeng JZ
Theranostics; 2020; 10(3):1230-1244. PubMed ID: 31938062
[No Abstract] [Full Text] [Related]
13. Role of beta-catenin in hepatocarcinogenesis of rats.
Wang QM; Yang KM; Zhou HY; Yu ZH; Li X; Yang HJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):85-9. PubMed ID: 16481290
[TBL] [Abstract][Full Text] [Related]
14. Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma.
Zhang F; Meng F; Li H; Dong Y; Yang W; Han A
Eur J Cancer; 2011 Sep; 47(13):2060-7. PubMed ID: 21561764
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation.
Lin HH; Peng YJ; Tsai MJ; Wu YY; Tsai TN; Huang HH; Shih YL; Chang WK; Hsieh TY
J Cell Physiol; 2020 Feb; 235(2):1689-1699. PubMed ID: 31298420
[TBL] [Abstract][Full Text] [Related]
17. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
18. Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage.
Yan Y; Zeng ZZ; Higashi S; Denda A; Konishi Y; Onishi S; Ueno H; Higashi K; Hiai H
Carcinogenesis; 2002 Jan; 23(1):189-96. PubMed ID: 11756240
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.
Picard E; Seguin C; Monhoven N; Rochette-Egly C; Siat J; Borrelly J; Martinet Y; Martinet N; Vignaud JM
J Natl Cancer Inst; 1999 Jun; 91(12):1059-66. PubMed ID: 10379969
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of retinoic acid receptors in normal and malignant esophageal tissues.
Kumar A; Kaur J; Chattopadhyay TK; Mathur M; Ralhan R
J Exp Ther Oncol; 2004 Apr; 4(1):1-8. PubMed ID: 15255287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
